SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06622005 · RECRUITING
Trial details
- NCT number
- NCT06622005
- Sponsor
- Roswell Park Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-10
- Primary completion
- 2027-04-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.